This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2012-2019.
Location History:
- Hanno, JP (2012)
- Tokyo, JP (2019)
Company Filing History:
Years Active: 2012-2019
Title: Kosuke Egami: Innovator in Antitumor Agents
Introduction
Kosuke Egami is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents, his work is recognized for its potential impact on cancer treatment.
Latest Patents
Egami's latest patents include a crystal of 3,5-disubstituted benzene alkynyl compound. This invention aims to provide a stable crystal of (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-pyrrolidinyl)-2-propen-1-one, which is useful as an antitumor agent. The crystal is noted for its excellent oral absorbability, high chemical purity, and suitability for mass production. Additionally, it exhibits an X-ray powder diffraction spectrum with characteristic peaks that are crucial for its identification and application.
Another significant patent involves an acylthiourea compound or its salt, which serves as a c-Met inhibitory antitumor agent. This compound selectively targets tumor cells expressing c-Met, thereby mitigating side effects associated with traditional treatments. The formula includes various substituents that enhance its efficacy and specificity.
Career Highlights
Kosuke Egami is currently associated with Taiho Pharmaceutical Company Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a focus on developing compounds that can effectively combat cancer while minimizing adverse effects.
Collaborations
Egami has collaborated with notable colleagues, including Yoshimitsu Suda and Hidenori Fujita. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Kosuke Egami's contributions to the field of antitumor agents highlight his role as a key innovator in pharmaceuticals. His patents reflect a commitment to improving cancer treatment through innovative compounds.